Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis
Goldmann DA, Weinstein RA, Wenzel RP, et al.
Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA
Goldmann DA, Huskins WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis
Shlaes DM, Gerding DN, John JF Jr, et al.
Society for Healthcare Epidemiology and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis
Riebet HM, Mohammed J, McDonald LC, Jarvis WR. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis
Dellit TH, Owens RC, McGowan JE Jr., et al.
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis
McGowan JE Jr.
Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis
Courcol RJ, Pinkas M, Martin GR. A seven year survey of antibiotic susceptibility and its relationship with usage. J Anti-microb Chemother
Chow JW, Fine MJ, Shlaes DM, et al.
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med
Conus P, Francioli P. Relationship between ceftriaxone use and resistance of Enterobacter species. J Clin Pharm Ther
Seppala H, Klaukka T, Vuopio-Varkila J, et al.
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med
Rahal JJ, Urban C, Horn D, et al.
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA
Muller AA, Mauny F, Bertin M, et al.
Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis
Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB. Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis
Paterson DL, Ko WC, Von GA, et al.
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med
Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis
Schentag JJ, Ballow CH, Fritz AL, et al.
Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis
Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol
LaRocco A Jr. Concurrent antibiotic review programs: a role for infectious diseases specialists at small community hospitals. Clin Infect Dis
Ansari F, Gray K, Nathwani D, et al.
Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother
Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis
Lutters M, Harbarth S, Janssens JP, et al.
Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc
John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis
Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol
Stone PW. Methods for conducting and reporting cost-effectiveness analysis in nursing. Image J Nurs Sch
Lipworth AD, Hyle EP, Fishman NO, et al.
Limiting the emergence of extended-spectrum β-lactamase-producing enterobac-teriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol
Fishman N. Antimicrobial stewardship. Am J Med
Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium dibicüe-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis
2007; 45(suppl 2):S112–S121.
Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med
Slain D, Sarwari AR, Petros KO, et al.
Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract
Eddy DM. A Manual for Assessing Health Practices and Designing Health Policies. Philadelphia: The American College of Physicians, 1992.
Stone PW, Schackman BR, Neukermans CP, et al.
A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis
Stone PW. Return-on-investment models. Appi Nurs Res
Zilberberg MD, Shorr AF. Understanding cost-effectiveness. Clin Microbiol Infect
Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Phn
Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother
Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control
Neumann PJ, Greenberg D, Olchanski NV, Stóne PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value Health
Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA
Gold MR, Siegel JE, Russell LB, and Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA
Ward WJ Jr, Spragens L, Smithson K. Building the business case for clinical quality. Healthc Einanc Manage
Roberts RR, Frutos PW, Ciavarella GG, et al.
Distribution of variable vs fixed costs of hospital care. JAMA
Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis
Stone PW. Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res
Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med
Engemann JJ, Carmeli Y, Cosgrove SE, et al.
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis
Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol
Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis
Kamai J, Rogers P, Saltz J, Mekhjian H. Information warehouse as a tool to analyze computerized physician order entry order set utilization: opportunities for improvement. AMIA Annu Symp Proc
Schwartz DN, Evans RS, Camins C, et al.
Deriving measures of intensive care unit antimicrobial use from computerized pharmacy data: methods, validation, and overcoming barriers. Infect Control Hosp Epidemiol
Lodise TP Jr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis